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ABSTRACT 
Introduction: We have previously shown that protein ingestion prior to sleep increases 
overnight muscle protein synthesis rates. Whether prior exercise further augments the muscle 
protein synthetic response to pre-sleep protein ingestion remains to be established. Objective: 
To assess whether resistance-type exercise performed in the evening increases the overnight 
muscle protein synthetic response to pre-sleep protein ingestion. Methods: Twenty four healthy 
young men were randomly assigned to ingest 30 g intrinsically L-[1-
13
C]-phenylalanine and L-
[1-
13
C]-leucine labeled casein protein before going to sleep with (PRO+EX: n=12) or without 
(PRO: n=12) prior resistance-type exercise performed in the evening. Continuous intravenous L-
[ring-
2
H5]-phenylalanine, L-[1-
13
C]-leucine and L-[ring-
2
H2]-tyrosine infusions were applied. 
Blood and muscle tissue samples were collected to assess whole-body protein balance, 
myofibrillar protein synthesis rates and overnight incorporation of dietary protein-derived amino 
acids into de novo myofibrillar protein. Results: A total of 571% of the ingested protein-
derived phenylalanine appeared in the circulation during overnight sleep. Overnight myofibrillar 
protein synthesis rates were 37% (0.0550.002 vs 0.0400.003 %∙h-1, P<0.001; based upon L-
[ring-
2
H5]-phenylalanine) and 31% (0.0730.004 vs 0.0550.006 %∙h
-1
, P=0.024; based upon L-
[1-
13
C]-leucine) higher in PRO+EX compared to PRO. Substantially more of the dietary protein-
derived amino acids were incorporated into de novo myofibrillar protein during overnight sleep 
in PRO+EX compared to PRO (0.0260.003 vs 0.0150.003 MPE, P=0.012). Conclusions: 
Resistance-type exercise performed in the evening augments the overnight muscle protein 
synthetic response to pre-sleep protein ingestion and allows more of the ingested protein-derived 
amino acids to be used for de novo myofibrillar protein synthesis during overnight sleep. 
Keywords: sleep, recovery, exercise, muscle, stable isotopes, casein
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INTRODUCTION 
A single session of resistance-type exercise stimulates both muscle protein synthesis and 
breakdown rates (4, 23, 28). Protein ingestion after exercise stimulates muscle protein synthesis 
and inhibits muscle protein breakdown, resulting in net muscle protein accretion during the acute 
stages of post-exercise recovery (5, 7, 15). Therefore, post-exercise protein ingestion is widely 
applied as a strategy to increase post-exercise muscle protein synthesis rates and, as such, to 
stimulate post-exercise recovery and facilitate skeletal muscle reconditioning. Various factors 
have been identified that can modulate the post-exercise muscle protein synthetic response 
including the amount (20, 31), type (27, 30) and timing (1, 18) of protein ingestion.  
Previously, we have demonstrated that protein ingested prior to sleep is properly digested and 
absorbed, thereby increasing overnight amino acid availability, and stimulating muscle protein 
synthesis during overnight sleep (13, 24). Based upon these findings we suggested that protein 
ingestion prior to sleep may represent a practical and effective interventional strategy to support 
muscle mass maintenance and/or stimulate muscle hypertrophy. In this regard, pre-sleep protein 
supplementation has recently been applied in a prolonged resistance-type exercise training 
regimen, allowing greater gains in muscle mass and strength (26). In this study, subjects ingested 
either ~30 g of additional protein or a noncaloric placebo prior to sleep during a 3 month 
resistance-type exercise training program, with supplements ingested on both training days (3 
times/wk) and non-training days. Though pre-sleep protein supplementation was effective in 
further increasing muscle mass and strength gains when compared to a placebo, the acute effects 
of resistance-type exercise on the muscle protein synthetic response to protein ingestion prior to 
sleep remains to be determined.  
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The aim of the present study was to assess whether resistance-type exercise performed in the 
evening increases the overnight muscle protein synthetic response to pre-sleep protein ingestion. 
We hypothesized that resistance-type exercise performed in the evening augments the muscle 
protein synthetic response to pre-sleep protein ingestion, allowing more of the ingested protein to 
be used for de novo myofibrillar protein accretion during overnight sleep. Therefore, we studied 
24 recreationally active young males who ingested 30 g intrinsically L-[1-
13
C]-phenylalanine and 
L-[1-
13
C]-leucine labeled casein protein before going to sleep with (PRO+EX) or without prior 
exercise (PRO) being performed in the evening. By combining the use of specifically produced 
intrinsically L-[1-
13
C]-phenylalanine and L-[1-
13
C]-leucine labeled casein with primed 
continuous infusion of L-[ring-
2
H5]-phenylalanine, L-[1-
13
C]-leucine and L-[ring-
2
H2]-tyrosine, 
we were able to assess protein digestion and amino acid absorption kinetics, whole-body protein 
metabolism, muscle protein synthesis rates as well as the metabolic fate of the dietary protein-
derived amino acids towards de novo myofibrillar protein accretion during overnight sleep.  
 
METHODS 
Subjects 
A total of 24 healthy, recreationally active (participating in exercise other than structured 
resistance-type exercise, for 1-3 d∙wk-1 for  12 months), young men were selected to participate 
in this study. Subjects’ characteristics are presented in Table 1. Subjects were randomly assigned 
to ingest 30 g intrinsically L-[1-
13
C]-phenylalanine and L-[1-
13
C]-leucine labeled casein protein 
before going to sleep with (PRO+EX, n=12) or without a bout of resistance-type exercise (PRO, 
n=12) being performed in the evening (19:45 – 20:45 PM). All subjects were fully informed of 
the nature and possible risks of the experimental procedures before their written informed 
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consent was obtained. This study is part of a greater project investigating the impact of pre-sleep 
protein feeding on overnight muscle protein synthesis. The project was registered at Netherlands 
Trial Registry as NTR3885, was approved by the Medical Ethical Committee of the Maastricht 
University Medical Centre, The Netherlands, and conformed to standards for the use of human 
subjects in research as outlined in the most recent version of the Helsinki Declaration.  
 
Pretesting 
Bodyweight and body composition (fat and fat-free mass) were determined by DEXA (Dual–
energy X-ray absorptiometry, DEXA; Discovery A; Hologic, Bedford, USA). Leg volume was 
determined by anthropometry measurements as described by Jones and Pearson (14). The 
subjects were then familiarized with the resistance-type exercise protocol and the exercise 
equipment. All exercises during pretesting and experimental trials were supervised by trained 
personnel. Subjects started by performing a 10-min cycling warm-up at 150 W before 
completing an estimation of their 1RM on the leg press and leg extension exercises using the 
multiple repetitions testing procedure (19). For each exercise, subjects performed 10 submaximal 
repetitions to become familiarized with the equipment and to have lifting technique critiqued and 
properly adjusted. Sets were then performed at progressively increasing loads until failure to 
perform a valid estimation within 3-6 repetitions of the set. A repetition was valid if the subject 
was able to complete the entire lift in a controlled manner without assistance. A 2 min resting 
period between subsequent attempts was allowed. The pretesting and experimental trials were 
separated by at least 7 d. 
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Diet and physical activity 
All subjects were instructed to refrain from exhaustive physical labor and exercise and to keep 
their diet as constant as possible 2 d before the experimental day. Food intake and physical 
activity questionnaires were collected for 2 d prior to the experiment. All subjects received a 
standardized diet throughout the experimental day (0.16 MJ·kg
-1
, providing 62 energy 
percentage (En%) carbohydrate, 13 En% protein, and 22 En% fat). The energy content of the 
standardized diet was based upon individual energy requirements based upon the Harris-
Benedict equation and adjusted using a physical activity factor of 1.6 to ensure ample energy 
intake. During the experimental day, participants ingested 1.2±0.01 g protein·kg bodyweight
-1
 
via the standardized diet with an additional 20 g (0.27±0.01 g·kg
-1
) of protein provided at 20:45 
h and an additional 30 g of protein (0.40±0.01 g·kg
-1
) provided prior to sleep (23:30 h).  
 
Experimental Protocol 
An outline of the study protocol is provided in Figure 1. At 17:30 h, participants reported to the 
lab and had Teflon catheters inserted into the antecubital veins of each arm. At 18:30 h (t= -300 
min), all the subjects consumed a standardized dinner (Sligro, Maastricht, the Netherlands) under 
supervision (0.04 MJ·kg
-1
, providing 55 En% carbohydrate, 21 En% protein, and 20 En% fat), 
after which no more solid food was consumed. Subjects in the PRO+EX group subsequently 
performed a resistance-type exercise bout between 19:45 and 20:45 h. Subjects in the PRO group 
rested in a sitting position during this period. Immediately after the exercise or rest session, both 
the PRO and PRO+EX group received drinks providing 20 g protein and 45 g carbohydrate 
(Gatorade G-series 03 Recover protein recovery shake, the Gatorade Company, Chicago, USA), 
which were ingested within 2 min. The purpose of this recovery drink was to optimize muscle 
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protein synthesis rates in the hours prior to sleep (2). Following protein ingestion, a background 
blood sample was taken prior to the initiation of the tracer infusion protocol, which was started at 
21:00 h (t= -150 min). The plasma and intracellular phenylalanine and leucine pools were primed 
with a single intravenous dose (priming dose) of L-[ring-
2
H5]-phenylalanine (2.0 µmol·kg
-1
), L-
[ring-
2
H2]-tyrosine (0.615 µmol·kg
-1
), and L-[1-
13
C]-leucine (4.0 µmol·kg
-1
). Once primed, the 
continuous stable isotope infusion was initiated (infusion rate: 0.05 µmol·kg
-1
·min
-1
 L-[ring-
2
H5]-phenylalanine, 0.015 µmol·kg
-1
·min
-1 
L-[ring-
2
H2]-tyrosine, 0.1 µmol·kg
-1
·min
-1 
L-[1-
13
C]-
leucine): Cambridge Isotopes Laboratories, Andover, MA). Participants rested in a supine 
position for 2.5 h until 23:30 h (t= 0 min), after which the first muscle biopsy was taken. 
Subsequently, subjects ingested a 450 mL beverage containing 30 g intrinsically L-[1-
13
C]-
phenylalanine and L-[1-
13
C]-leucine labeled casein with an added 1.5 mL of vanilla extract (Dr. 
Oetker, Amersfoort, the Netherlands) within 5 min. Subjects went to sleep at 00:00 h. During the 
night, blood samples (10 mL) were taken without waking up the subjects at t= 30, 60, 90, 150, 
210, 330, and 450 min relative to the intake of the protein drink. A second muscle biopsy was 
obtained from the contralateral leg 7.5 h later at 07:00 h (t= 450 min).  
Blood samples were collected in tubes containing EDTA and centrifuged at 1000 g for 10 min at 
4°C. Aliquots of plasma were frozen in liquid nitrogen and stored at –80°C. Muscle biopsies 
were obtained from the middle region of the M. vastus lateralis, 15 cm above the patella and 
approximately 4 cm below entry through the fascia, using the percutaneous needle biopsy 
technique (3). Muscle samples were dissected carefully and freed from any visible non-muscle 
material. The muscle samples were immediately frozen in liquid nitrogen and stored at –80°C 
until further analysis. 
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Exercise protocol 
The exercise protocol consisted of 60 min of lower-body resistance-type exercise. After 15 min 
of self-paced cycling at 150 W with a cadence of 60–80 rpm, subjects performed 6 sets of 10 
repetitions on the horizontal leg press machine (Technogym BV, Rotterdam, Netherlands) and 6 
sets of 10 repetitions on the leg extension machine (Technogym BV). The first two sets of both 
exercises were performed at 55% and 65% of the subjects’ 1RM, respectively. Sets 3–6 were 
performed at 75% of 1RM and there were 2-min rest intervals between all sets. Immediately after 
the exercise session, both the PRO and PRO+EX group received drinks providing 20 g protein 
and 45 g carbohydrate (Gatorade G-series 03 Recover protein recovery shake, the Gatorade 
Company, Chicago, USA). 
 
Production of intrinsically labeled protein 
Intrinsically L-[1-
13
C]-phenylalanine and L-[1-
13
C]-leucine labeled casein protein was obtained 
during the constant infusion of L-[1-
13
C]-phenylalanine (455 µmol·min
-1
) and L-[1-
13
C]-leucine 
(200 µmol·min
-1
) maintained for 96 h in a lactating dairy cow. The milk was collected, 
processed, and fractionated into the casein protein concentrate as previously described (8, 22, 
29). The L-[1-
13
C]-phenylalanine and L-[1-
13
C]-leucine enrichments in casein protein were 
measured by gas chromatography-combustion-isotope ratio mass spectrometry (GC-IRMS; MAT 
252, Finnigan, Breman, Germany) and averaged 38.7 molar percent excess (MPE) and 9.3 MPE, 
respectively. The proteins met all chemical and bacteriological specifications for human 
consumption.  
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Tracer preparation 
The stable isotope tracers L-[ring-
2
H5]-phenylalanine, L-[1-
13
C]-leucine and L-[ring-
2
H2]-
tyrosine were purchased from Cambridge Isotopes (Andover, MA) and dissolved in 0.9% saline 
before infusion (Basic Pharma, Geleen, the Netherlands). Continuous intravenous infusions were 
performed using a calibrated IVAC 598 pump (San Diego, CA, USA).  
 
Plasma analysis 
Plasma glucose and insulin concentrations were analyzed using commercially available kits 
(GLUC3, Roche, Ref: 05168791 190, and Immunologic, Roche, Ref: 12017547 122, 
respectively). Plasma amino acid concentrations and enrichments were determined by gas 
chromatography-mass spectrometry analysis (GC-MS; Agilent 7890A GC/5975C; MSD, 
Wilmington, Delware, USA). Specifically, internal standards of [U-
13
C6]-leucine, [U-
13
C9
15
N]-
phenylalanine, and [U-
13
C9
15
N]-tyrosine were added to the samples. The plasma was 
deproteinized on ice with dry 5-sulfosalicylic acid. Free amino acids were purified using cation 
exchange chromatography (AG 50W-X8 resin; mesh size: 100-200 µm, ionic form: hydrogen; 
Bio-Rad Laboratories, Hercules, USA). The purified amino acids were converted into tert-butyl 
dimethylsilyl (tert-BDMS) derivatives with MTBSTFA before analysis by GC-MS. The amino 
acid concentrations were determined using electron impact ionization by monitoring ions at 
mass/charge (m/z) 302 and 308 for unlabeled and [U-
13
C6] labeled-leucine, 336 and 346 for 
unlabeled and [U-
13
C9
15
N] labeled-phenylalanine respectively, and 466 and 476 for unlabeled 
and [U-
13
C9
15
N]-tyrosine, respectively. The plasma leucine, phenylalanine, and tyrosine 
13
C and 
2
H enrichments were determined using selective ion monitoring at m/z 302 and 303 for unlabeled 
and labeled (1-
13
C) leucine, respectively; m/z 336, 337 and 341 for unlabeled and labeled (1-
13
C 
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and ring-
2
H5) phenylalanine, respectively; m/z 466, 467, 468 and 470 for unlabeled and labeled 
(1-
13
C, ring-3,5-
2
H2, and ring-
2
H4) tyrosine, respectively. Standard regression curves were 
applied from a series of known standard enrichment values against the measured values to assess 
the linearity of the mass spectrometry and to account for any isotopic fractionation. 
 
Muscle analysis 
Myofibrillar protein enriched fractions were extracted from ~60 mg of wet muscle tissue by 
hand-homogenizing on ice using a pestle in a standard extraction buffer (7 L·mg-1) (16). The 
samples were spun at 2500 g and 4 ºC for 5 min. The pellet was washed with 500 µL ddH2O and 
centrifuged at 250 g and 4 ºC for 10 min. The myofibrillar protein was solubilized by adding 1 
mL of 0.3 M NaOH and heating at 50 ºC for 30 min with vortex mixing every 10 min. Samples 
were centrifuged at 9500 g and 4 ºC for 5 min, the supernatant containing the myofibrillar 
proteins was collected and the collagen pellet was discarded. Myofibrillar proteins were 
precipitated by the addition of 1 mL of 1 M PCA and spinning at 700 g and 4 ºC for 10 min. The 
myofibrillar protein was washed twice with 70% ethanol and hydrolyzed overnight in 2 mL of 6 
M HCL at 110˚C. The free amino acids from the hydrolyzed myofibrillar protein pellet were 
dried under nitrogen stream while being heated to 120 ºC. The free amino acids were then 
dissolved in 25% acetic acid solution, passed over cation exchange AG 50W-X8 resin columns 
(mesh size: 100-200, ionic form: hydrogen; Bio-Rad Laboratories, Hercules, CA), and eluted 
with 2 M NH4OH. The purified amino acids were divided into 2 aliquots to determine the L-
[ring-
2
H5]-phenylalanine enrichments by GC-MS analysis and the L-[1-
13
C]-phenylalanine and 
L-[1-
13
C]-leucine enrichments by gas chromatography-combustion-isotope ratio mass 
spectrometry (GC-IRMS) analysis. To reduce the signal-to-noise ratio during GC-MS analysis at 
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low tracer enrichments, the phenylalanine from the myofibrillar protein hydrolysates was 
enzymatically decarboxylated to β-phenylethylamine prior to derivatization with MTBSTFA. To 
determine myofibrillar protein L-[1-
13
C]-phenylalanine and L-[1-
13
C]-leucine enrichments by 
GC-IRMS analysis, the purified amino acids were converted into N-ethoxycarbonyl ethyl ester 
derivatives with ethyl chloroformate (ECF). The derivatives were then measured by GC-IRMS 
(Finnigan MAT 253, Bremen, Germany) using a DB5-MS-column (no. 122-5532; Agilent J+W 
scientific GC Column), GC Isolink, and monitoring of ion masses 44, 45 and 46. Standard 
regression curves were applied to assess the linearity of the mass spectrometer and to account for 
isotopic fractionation. 
 
Calculations 
Ingestion of L-[1-
13
C]-phenylalanine labeled protein, intravenous infusion of L-[ring-
2
H5]-
phenylalanine, and L-[ring-3,5-
2
H2]-tyrosine, and blood sample enrichment values were used to 
assess whole-body amino acid kinetics in non-steady state conditions. Total, exogenous, and 
endogenous phenylalanine rate of appearance (Ra) and plasma availability of dietary protein-
derived phenylalanine that appeared in the systemic circulation as a fraction of total amount of 
phenylalanine that was ingested (Pheplasma) were calculated using modified Steele’s equations (6, 
10). 
These parameters were calculated as follows: 
           
            
    
  
 
      
      (1) 
 
        
                             
    
  
 
     
                       (2)     
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                   –        –         (3) 
   
             
        
       
                                      (4) 
 
where F is the intravenous tracer infusion rate (µmol∙kg-1∙min-1), and pV (0.125 L∙kg-1) is the 
distribution volume for phenylalanine (6). C(t) is the mean plasma phenylalanine concentration 
between 2 consecutive time points. dEiv/dt represents the time-dependent variations of plasma 
phenylalanine enrichment derived from the intravenous tracer and Eiv (t) is the mean plasma 
phenylalanine enrichment from the intravenous tracer between 2 consecutive time points. ExoRa 
represents the plasma entry rate of dietary phenylalanine, Epo (t) is the mean plasma 
phenylalanine enrichment for the ingested tracer, dEpo/dt represents the time-dependent 
variations of plasma phenylalanine enrichment derived from the oral tracer and Eprot is the L-[1-
13
C]-phenylalanine enrichment in the dietary protein. Pheplasma is the percentage of ingested 
dietary phenylalanine that becomes available in the plasma and is calculated using PheProt and 
AUCExoRa. PheProt is the amount of dietary phenylalanine ingested and AUCExoRa represents the 
area under the curve (AUC) of ExoRa, which corresponds to the amount of dietary phenylalanine 
that appeared in the blood over a 7.5 h period following ingestion. 
Total rate of disappearance of phenylalanine equals the rate of phenylalanine hydroxylation (first 
step in phenylalanine oxidation) and utilization for protein synthesis. This parameter is 
calculated as follows: 
 
                     
  
  
     (5) 
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Because whole-body Rd comprises the rate of phenylalanine disappearance from the free amino 
acid pool in the blood due to protein synthesis and oxidation, whole-body protein synthesis can 
be calculated as Rd minus oxidation. Whole-body phenylalanine oxidation can be determined 
from the conversion (hydroxylation) of L-[ring-
2
H5]-phenylalanine to L-[ring-
2
H4]-tyrosine. The 
rate of hydroxylation was calculated by using the following formula: 
 
                         
     
     
 
     
          
                     (6) 
 
TyrRa represents the rate of appearance of L-[ring-
2
H4]-tyrosine; Et(t) and Ep(t) are the L-[ring-
2
H4]-tyrosine and L-[ring-
2
H5]-phenylalanine enrichments in plasma between 2 consecutive time 
points, respectively and F is the infusion rate of phenylalanine. Whole-body protein synthesis 
was calculated using: 
 
                                          (7)  
 
Whole-body protein net balance was calculated as AUC over the 7.5 h post-prandial phase using 
whole-body protein synthesis minus endogenous Ra.   
   
                                            (8) 
 
The fractional synthesis rate (FSR) of myofibrillar protein was calculated by dividing the 
increment in enrichment in the product, i.e. protein-bound L-[1-
13
C]-leucine or L-[ring-
2
H5]-
phenylalanine, by the enrichment of the respective precursor amino acid enrichments (i.e., 
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plasma free amino acids). Weighted mean plasma L-[ring-
2
H5]-phenylalanine and L-[1-
13
C]-
leucine enrichments were used as the preferred precursor pools to estimate myofibrillar protein 
fractional synthesis rates from the continuously infused L-[ring-
2
H5]-phenylalanine, and L-[1-
13
C]-leucine tracers. Consequently, myofibrillar FSR was calculated as follows (17): 
 
       
            
          
  
  
                                                   (9) 
 
where EB represents muscle protein bound L-[ring-
2
H5]-phenylalanine or L-[1-
13
C]-leucine. EF 
represent the average plasma L-[ring-
2
H5]-phenylalanine or L-[1-
13
C]-leucine enrichment during 
the tracer incorporation period. t Indicates the time interval (h) between biopsies. 
 
Sleep quality assessment 
The Pittsburg Sleep Quality Index (PSQI, Sleep Medicine Institute, University of Pittsburgh) was 
used to assess habitual sleep quality during pretesting (9).  PSQI scoring (global scores 0-21 
points; higher scores indicate worse sleep quality) was used to classify all subjects to very good, 
good, poor or very poor sleepers. Subjects that scored >5 (poor sleepers) were not included in the 
trial. Sleep behavior during the test night was monitored using wrist activity monitors (Philips 
Respironics, Bend, USA). Additionally, the start and end time of sleep were recorded throughout 
the trial. The following parameters were derived from sleep records and activity monitors: sleep 
time (clock time), wake time (clock time), sleep onset latency (the period of time between bed 
time and sleep start), sleep duration (h), time awake/light sleep (h), sleep efficiency (%, sleep 
duration expressed as a percentage of time in bed), and wake bouts.  
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Statistics 
All data are expressed as means±SEM. A sample size of 12 subjects per group including a 10% 
dropout rate was calculated with a power of 80% and an α-level of .05 to detect a 20% difference 
in FSR between groups. Baseline characteristics between groups were compared using a 
Student’s t-test. Time-dependent variables (i.e. plasma metabolite concentrations, plasma 
enrichments and whole-body protein kinetics) were analyzed by two-factor repeated measures 
ANOVA with time as within-subjects factor and treatment group as between-subjects factor. The 
analysis was carried out for the period starting at the time of protein administration, between t= 0 
and 450 min. Non time-dependent variables (i.e. FSR values) were compared between treatment 
groups using Student’s t-tests. Statistical significance was set at P<0.05. All calculations were 
performed using SPSS 21.0 (SPSS inc., Chicago, Illinois, USA). 
 
RESULTS 
 
Plasma analysis 
Plasma glucose and insulin concentrations are shown in (see Figure, SDC 1, plasma glucose and 
insulin concentrations, http://links.lww.com/MSS/A759). Both plasma glucose and plasma 
insulin concentrations were slightly lower in the PRO-EX vs PRO group throughout the 
overnight period (treatment effect: P<0.05). However, changes in plasma glucose and plasma 
insulin over time were not different between groups (time x treatment interaction: (P=0.476). 
Plasma insulin concentrations peaked at 30 min following protein ingestion at 9.1±2.2 and 
14.3±1.2 mU∙L-1 in the PRO and PRO+EX treatment, respectively.  
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Plasma phenylalanine (A), leucine (B), and tyrosine (C) concentrations are displayed in Figure 
2. Plasma amino acid concentrations increased over time, with no significant differences in 
plasma phenylalanine and leucine concentrations between treatments (time x treatment 
interaction: P>0.05). In contrast, a significant time x treatment interaction was found for plasma 
tyrosine (P=0.005).  
Figure 3 shows the plasma L-[ring-
2
H5]-phenylalanine, L-[1-
13
C]-leucine, and L-[1-
13
C]-
phenylalanine enrichments (MPE). Plasma tracer enrichments did not differ between treatments 
before ingesting the protein (t= 0 min, P>0.05). Following protein ingestion, plasma L-[ring-
2
H5]-phenylalanine and L-[1-
13
C]-leucine enrichments increased slightly over time, but this 
increase over time did not differ between treatments (time x treatment interaction, P>0.05). 
Plasma L-[1-
13
C]-phenylalanine enrichments, originating from the ingested protein, increased in 
both treatments, reaching maximal values of 9.39±0.42 MPE at t= 90 min in PRO and 9.89±0.44 
MPE at t= 150 min in the PRO+EX treatment, and remained elevated above basal levels for the 
duration of the night with no differences over time between treatments (time x treatment 
interaction: P=0.365). 
 
Whole-body amino acid kinetics 
Plasma amino acid kinetics data are presented in (see Figure, SDC 2, plasma amino acid kinetics, 
http://links.lww.com/MSS/A760). Exogenous phenylalanine appearance rates increased 
following protein ingestion with no differences between treatments (time x treatment interaction: 
P=0.334). Endogenous phenylalanine appearance rates declined following protein ingestion, with 
no differences between treatments (time x treatment interaction: P=0.179). Over the entire 7.5 h 
post-prandial period, 59.0±1.8 and 55.8±1.7% (PRO and PRO+EX, respectively) of the ingested 
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dietary protein-bound phenylalanine appeared in the plasma circulation, with no differences 
between treatments (P=0.205).    
Whole-body protein metabolism data are expressed in Figure 4. Protein ingestion prior to sleep 
resulted in positive overnight whole-body protein net balance with no differences observed 
between treatments (PRO: 51.1±1.5 vs PRO+EX: 53.0±1.9 µmol phenylalanine·kg
-1
·7.5 h
-1
, 
P=0.436). Furthermore, resistance-type exercise did not appear to further influence any other 
parameters of whole-body protein metabolism. 
 
Myofibrillar protein fractional synthesis rates and protein-bound enrichments 
Myofibrillar protein fractional synthetic rates (FSR) based upon L-[ring-
2
H5]-phenylalanine 
infusion with plasma L-[ring-
2
H5] enrichments as precursor (A: FSR in %∙h
-1
) or using L-[1-
13
C]-leucine ingestion and infusion with plasma L-[1-
13
C]-leucine enrichments as precursor (B, 
FSR in %∙h-1) are displayed in Figure 5. Exercise prior to protein ingestion before sleep resulted 
in greater stimulation of overnight myofibrillar FSR calculated based upon L-[ring-
2
H5]-
phenylalanine (0.055±0.002 vs 0.040±0.003 %∙h-1, P<0.001) as well as L-[1-13C]-leucine 
(0.073±0.004 vs 0.055±0.006 %∙h-1, P=0.024). Overnight FSR were 37% or 31% higher in the 
PRO+EX compared with the PRO treatment, based upon L-[ring-
2
H5]-phenylalanine and L-[1-
13
C]-leucine infusion, respectively.  
Myofibrillar L-[1-
13
C]-phenylalanine enrichments (MPE) increased following the ingestion of 
intrinsically L-[1-
13
C]-phenylalanine labeled protein, reaching values of 0.026±0.003 vs 
0.015±0.003 MPE in the PRO+EX and PRO treatment, respectively (P=0.012; Figure 5C). 
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Sleep Data 
Sleep analysis data are presented in (see Table, SDC 3, sleep analysis 
datahttp://links.lww.com/MSS/A761). Total sleep duration did not differ between the treatments 
(PRO: 6:05±0:10 vs PRO+EX: 6:00±0:11 (h:mm), P=0.794). In addition, there were no 
significant differences between the treatments in sleep time, wake time, sleep onset latency (the 
period of time between bedtime and sleep start), or sleep efficiency (% sleep duration expressed 
as a percentage of time in bed). 
 
DISCUSSION 
The present study demonstrates that protein ingested prior to sleep is properly digested and 
absorbed, with 55% of the ingested protein-derived amino acids appearing in the systemic 
circulation throughout overnight sleep. Resistance-type exercise performed earlier in the evening 
increases myofibrillar protein synthesis rates during overnight sleep, and improves the efficiency 
by which the pre-sleep dietary protein-derived amino acids are directed towards overnight de 
novo myofibrillar protein synthesis.  
In the present study we combined the ingestion of specifically produced intrinsically L-[1-
13
C]-
phenylalanine labeled protein with continuous intravenous infusion of L-[ring-
2
H5]-
phenylalanine to allow us to assess dietary protein digestion and amino acid absorption kinetics 
during overnight sleep. Ingestion of 30 g casein protein was followed by proper protein digestion 
and subsequent amino acid absorption, as indicated by the post-prandial increase in plasma 
phenylalanine concentrations (Figure 2A) and L-[1-
13
C]-phenylalanine enrichments (Figure 3C). 
Exogenous dietary protein-derived phenylalanine appearance rates remained elevated throughout 
overnight sleep (see Figure, SDC 2, plasma amino acid kinetics, 
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http://links.lww.com/MSS/A760), with 57±1% of the ingested protein-derived amino acids being 
released in the circulation over the entire 7.5 h overnight period. These data are in line with 
previous observations showing 50% of ingested protein becoming available in the systemic 
circulation during a 5-7 h post-prandial period (11, 12, 24). We extend upon our previous work, 
with the observation that resistance-type exercise performed earlier in the evening does not 
impair the digestion and absorption of protein ingested prior to sleep.  
We have previously shown that ingestion of 40 g protein prior to sleep increases whole-body 
protein synthesis, resulting in a positive protein net balance during overnight sleep (24). In the 
current study, we observed that a more moderate 30 g protein dose likewise improves whole-
body protein synthesis rates and allows for a positive whole-body protein net balance (Figure 4). 
Prior resistance-type exercise did not further modulate overnight whole-body protein synthesis, 
breakdown, amino acid oxidation or net balance following pre-sleep protein ingestion (Figure 4). 
As whole-body protein kinetics do not necessarily reflect skeletal muscle metabolism, we also 
collected muscle biopsies before and after overnight sleep to assess the impact of resistance-type 
exercise on the overnight muscle protein synthetic response to pre-sleep protein feeding.  
As hypothesized, resistance-type exercise augmented overnight skeletal muscle reconditioning, 
with muscle protein synthesis rates being 37% (L-[ring-
2
H5]-phenylalanine, Figure 5A) and 31% 
(L-[1-
13
C]-leucine, Figure 5B) higher in the exercise compared with the non-exercise control 
group. These data are in line with the greater anabolic response to protein ingestion following 
exercise observed in the morning after an overnight fast (21, 25, 31). The present study extends 
upon these findings with the observation that resistance-type exercise increases the overnight 
muscle protein synthetic response to pre-sleep protein ingestion. In addition to the applied 
continuous infusions of L-[ring-
2
H5]-phenylalanine and L-[1-
13
C]-leucine to measure 
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myofibrillar protein synthesis rates, the ingestion of highly enriched (>35%) intrinsically L-[1-
13
C]-phenylalanine labeled protein allowed us to also directly assess the metabolic fate of the 
pre-sleep dietary protein-derived amino acids. We were able to measure L-[1-
13
C]-phenylalanine 
enrichments in myofibrillar protein following pre-sleep protein ingestion (Figure 5C), 
demonstrating that the pre-sleep protein-provided amino acids as precursors for de novo 
myofibrillar protein synthesis during overnight sleep. Substantially more (76%) more of the 
dietary protein-derived phenylalanine was incorporated in myofibrillar protein when resistance-
type exercise was performed earlier in the evening. These data indicate that prior resistance-type 
exercise increases the efficiency by which pre-sleep protein-derived amino acids are directed 
towards de novo muscle protein synthesis during overnight sleep.    
We have previously shown that protein ingestion before sleep increases muscle mass and 
strength gains during a 12-wk resistance-type exercise training program (26). Our current data 
show that resistance-type exercise performed earlier in the evening enhances the muscle protein 
synthetic response to pre-sleep protein ingestion. Therefore, protein ingestion prior to sleep 
represents an effective strategy to augment overnight skeletal muscle reconditioning and is even 
more relevant on exercise training days. 
In conclusion, resistance-type exercise performed in the evening augments the overnight muscle 
protein synthetic response to pre-sleep protein ingestion and allows more of the ingested protein-
derived amino acids to be used for de novo myofibrillar protein synthesis during overnight sleep. 
Combing pre-sleep protein ingestion with resistance-type exercise represents an effective 
strategy to maximize overnight skeletal muscle reconditioning. 
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FIGURE LEGENDS 
 
Figure 1. Experimental protocol. A drink with 20 g milk protein isolate and 45 g of carbohydrate 
was ingested at 20:45 h and a drink with 30 g intrinsically labeled casein protein was ingested at 
23:30 h. Subjects were randomly assigned to perform a single bout of resistance-type exercise or 
to remain rested between 19:45 h and 20:45 h. 
 
Figure 2. Overnight plasma phenylalanine (A), leucine (B) and tyrosine (C) concentrations 
(µmol∙L-1). The dotted line represents the ingestion of the treatment. Values represent 
means±SEM. Data were analyzed with a two-way repeated-measures (time x treatment) 
ANOVA. Phenylalanine: time effect: P<0.001; treatment effect: P=0.212; time x treatment 
interaction: P=0.275. Leucine: time effect: P<0.001; treatment effect: P=0.741; time x treatment 
interaction: P=0.524. Tyrosine: time effect: P<0.001; treatment effect: P=0.877; time x treatment 
interaction: P=0.005. PRO: pre-sleep protein ingestion without prior exercise, PRO+EX: pre-
sleep protein ingestion with prior exercise.  
 
Figure 3. Overnight plasma L-[ring-
2
H5]-phenylalanine (A), L-[1-
13
C]-leucine (B), L-[1-
13
C]-
phenylalanine (C) enrichments in mole percent excess (MPE). The dotted line represents the 
ingestion of the treatment. Values represent means±SEM. Data were analyzed with repeated-
measures (time x treatment) ANOVA. L-[ring-
2
H5]-phenylalanine enrichment: time effect: 
P<0.001; treatment effect: P=0.530; time x treatment interaction: P=0.445. L-[1-
13
C]-
phenylalanine enrichment: time effect: P<0.001; treatment effect: P=0.446; time x treatment 
interaction: P=0.365. L-[1-
13
C]-leucine enrichment: time effect: P<0.001; treatment effect: 
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P=0.164; time x treatment interaction: P=0.236. PRO: pre-sleep protein ingestion without prior 
exercise, PRO+EX: pre-sleep protein ingestion with prior exercise. 
 
Figure 4. Calculated rates of overnight whole-body protein synthesis, breakdown, oxidation, and 
net protein balance (µmol phenylalanine∙kg-1∙7.5 h-1). Values represent means±SEM. Data were 
analyzed with a Student’s t-test. No significant differences were detected (P>0.05). PRO: pre-
sleep protein ingestion without prior exercise, PRO+EX: pre-sleep protein ingestion with prior 
exercise.   
 
Figure 5. Overnight myofibrillar protein fractional synthetic rates (FSR) as calculated using L-
[ring-
2
H5]-phenylalanine (A), or L-[1-
13
C]-leucine (B) as tracer, and overnight L-[1-
13
C]-
phenylalanine incorporation in myofibrillar protein (mole percent excess, MPE, C). Values 
represent means±SEM. Data were analyzed with a Student’s t-test. *Significantly different from 
PRO (P<0.05). PRO: pre-sleep protein ingestion without prior exercise, PRO+EX: pre-sleep 
protein ingestion with prior exercise.   
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Table 1. Subjects’ characteristics 
 PRO  
(n=12) 
PRO+EX 
(n=12) 
Age (y) 24±1 23±1 
Weight (kg) 77.6±1.2 73.0±1.7* 
BMI (kg∙m-2) 21.9±0.4 22.1±0.5 
Fat (%) 13±1 14±1 
LBM (kg) 61.9±1.2 59.5±1.6 
Leg volume (L) 9.2±0.2 9.0±0.3 
 
Values represent means±SEM. PRO: pre-sleep protein ingestion without prior exercise, 
PRO+EX: pre-sleep protein ingestion with prior exercise. BMI: body mass index. * Significantly 
different from PRO (P=0.036). Data were analyzed with a Students’ t-test.  
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Supplemental material 
 
Supplemental Digital Content 1.docx—plasma glucose and insulin concentrations 
Supplemental Digital Content 2.docx—plasma amino acid kinetics 
Supplemental Digital Content 3.docx—sleep analysis data 
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Supplemental Figure 1. Overnight plasma glucose (A, mmol∙L-1) and insulin concentrations (B, 
mU∙L-1) following protein ingestion with (PRO+EX) and without (PRO) prior exercise. The 
dotted line represents the ingestion of the treatment.  Values represent means±SEM. Data were 
analyzed with a two-way repeated-measures (time x treatment) ANOVA. Glucose: time effect: 
P=0.004; treatment effect: P=0.0077; time x treatment interaction: P=0.075. Insulin: time effect: 
P<0.001; treatment effect: P=0.014; time x treatment interaction: P=0.476. 
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Supplemental Figure 2. Overnight exogenous phenylalanine rate of appearance (Ra) (A), 
endogenous phenylalanine Ra (B), total phenylalanine Ra (C), and total phenylalanine rate of 
disappearance (Rd) (D). The dotted line represents the ingestion of the treatment. Values 
represent means±SEM. Data were analyzed with repeated-measures (time x treatment) ANOVA. 
Exogenous phenylalanine Ra: time effect: P<0.001; treatment effect: P=0.957; time x treatment 
interaction: P=0.334. Endogenous phenylalanine Ra: time effect: P<0.001; treatment effect: 
P=0.368; time x treatment interaction: P=0.179. Total phenylalanine Ra: time effect: P<0.001; 
treatment effect: P=0.468; time x treatment interaction: P=0.366. Total phenylalanine Rd: time 
effect: P<0.001; treatment effect: P=0.421; time x treatment interaction: P=0.370. PRO: pre-
sleep protein ingestion without prior exercise, PRO+EX: pre-sleep protein ingestion with prior 
exercise. 
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Table 1. Subjects’ characteristics 
 PRO  
(n=12) 
PRO+EX 
(n=12) 
Age (y) 24±1 23±1 
Weight (kg) 77.6±1.2 73.0±1.7* 
BMI (kg∙m-2) 21.9±0.4 22.1±0.5 
Fat (%) 13±1 14±1 
LBM (kg) 61.9±1.2 59.5±1.6 
Leg volume (L) 9.2±0.2 9.0±0.3 
 
Values represent means±SEM. PRO: pre-sleep protein ingestion without prior exercise, 
PRO+EX: pre-sleep protein ingestion with prior exercise. BMI: body mass index. * Significantly 
different from PRO (P=0.036). Data were analyzed with a Students’ t-test.  
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